Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics crawled date : 2022 - 08 - 11 save search
Regulus Therapeutics Reports Second Quarter 2022 Financial Results and Recent Updates
Published: 2022-08-11 (Crawled : 22:00) - biospace.com/
RGLS | $2.16 -2.7% 70K
|
Health Technology
|
| O: 4.12%
H: 1.13%
C: -6.78%
therapeutics results
Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
Published: 2022-08-11 (Crawled : 22:00) - biospace.com/
LCTX | $1.175 -2.08% 240K
|
Health Technology
|
| O: 0.64%
H: 4.46%
C: -1.27%
therapeutics update results
VistaGen Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
Published: 2022-08-11 (Crawled : 22:00) - biospace.com/
VTGN | $4.655 -0.96% 17K
|
Health Technology
|
| O: 0.41%
H: 9.27%
C: 1.98%
therapeutics update results
Nabriva Therapeutics Completes Patient Enrollment in Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis- Topline Data Expected First Quarter 2023 -
Published: 2022-08-11 (Crawled : 16:00) - biospace.com/
NBRV | $1.42 1.39% 720K
|
Health Technology
|
| O: 2.74%
H: 10.14%
C: -0.87%
xenleta topline expected trial therapeutics cystic fibrosis phase 1
Entrada Therapeutics Reports Second Quarter 2022 Financial Results
Published: 2022-08-11 (Crawled : 16:00) - biospace.com/
TRDA | $11.895 -0.13% 8.2K
|
Professional, Scientific, and T...
|
| O: 8.8%
H: 0.0%
C: -7.43%
therapeutics results
Viracta Therapeutics Appoints Jane Chung, R.Ph., to its Board of Directors
Published: 2022-08-11 (Crawled : 16:00) - biospace.com/
VIRX | $0.909 7.9K
|
Manufacturing
|
| O: 7.32%
H: 2.17%
C: 1.77%
therapeutics
F-star Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
Published: 2022-08-11 (Crawled : 14:00) - biospace.com/
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: -1.06%
H: 1.22%
C: 0.31%
therapeutics results
Monte Rosa Therapeutics Reports Second Quarter 2022 Financial Results and Business Updates
Published: 2022-08-11 (Crawled : 14:00) - biospace.com/
GLUE | $5.985 1.1% 18K
|
Professional, Scientific, and T...
|
| O: 8.38%
H: 0.0%
C: -2.97%
MS | News 0 d | $90.92 0.73% 950K
|
Finance
|
| O: 1.23%
H: 0.96%
C: 0.24%
rosa therapeutics results
Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2022
Published: 2022-08-11 (Crawled : 13:00) - biospace.com/
SMMT A | $3.47 -1.14% 310K
|
Health Technology
|
| O: 1.92%
H: 5.66%
C: 2.83%
NKTR | $1.29 -2.27% 86K
|
Health Technology
|
| O: 1.44%
H: 2.85%
C: 0.61%
therapeutics
RAPT Therapeutics Reports Second Quarter 2022 Financial ResultsCompany maintains strong cash position of $207.3 million
Published: 2022-08-11 (Crawled : 13:00) - biospace.com/
RAPT | $7.76 -2.14% 73K
|
Health Technology
|
| O: 0.89%
H: 7.21%
C: 2.14%
therapeutics
NeuBase Therapeutics Reports Business Update and Financial Results for the Third Quarter of Fiscal Year 2022
Published: 2022-08-11 (Crawled : 13:00) - biospace.com/
NBSE | $0.411 -5.21% 480
|
Health Technology
|
| O: 2.56%
H: 0.0%
C: -5.0%
year therapeutics update
Pasithea Therapeutics Announces Results of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy in Relapsing-Remitting Model of Multiple Sclerosis
Published: 2022-08-11 (Crawled : 13:00) - biospace.com/
KTTA | $7.15 11
|
|
| O: 17.08%
H: 7.3%
C: -8.76%
preclinical vaccine therapeutics results sclerosis study multiple sclerosis
Werewolf Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Highlights
Published: 2022-08-11 (Crawled : 12:20) - biospace.com/
HOWL | $5.87 1.8K
|
Professional, Scientific, and T...
|
| O: 1.67%
H: 14.81%
C: 12.14%
therapeutics results
Aptevo Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
Published: 2022-08-11 (Crawled : 12:20) - biospace.com/
APVO 3 d | $0.769 -0.13% 120K
|
Health Technology
|
| O: 0.45%
H: 3.53%
C: -2.22%
therapeutics results
Monopar Therapeutics Reports Second Quarter 2022 Financial Results and Recent Program Developments
Published: 2022-08-11 (Crawled : 12:20) - globenewswire.com
MNPR | News | $0.636 -6.19% 16K
|
Health Technology
|
| O: -0.82%
H: 20.99%
C: 1.1%
program therapeutics results
Abeona Therapeutics Reports Second Quarter 2022 Financial Results
Published: 2022-08-11 (Crawled : 12:00) - biospace.com/
RARE F | $43.46 0.18% 39K
|
Health Technology
|
| O: -0.17%
H: 1.44%
C: -1.57%
ABEO | $7.365 -2.19% 99K
|
Health Technology
|
| O: -4.57%
H: 33.25%
C: 17.38%
therapeutics results
Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
Published: 2022-08-11 (Crawled : 12:00) - biospace.com/
GLAXF | $20.2 510
|
Health Technology
|
| O: -12.81%
H: 8.43%
C: 5.21%
GSK | $39.565 0.75% 170K
|
Health Technology
|
| O: -8.67%
H: 2.89%
C: 2.14%
FULC | $7.2 1.98% 40K
|
Health Technology
|
| O: -10.82%
H: 17.27%
C: 9.39%
therapeutics update results
Better Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-11 (Crawled : 12:00) - biospace.com/
BTTX | $0.009 180K
|
|
| O: 4.47%
H: 1.07%
C: -4.28%
EXEL | $22.46 -0.13% 320K
|
Health Technology
|
| O: 0.15%
H: 1.79%
C: -1.54%
therapeutics update results
Century Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates
Published: 2022-08-11 (Crawled : 12:00) - globenewswire.com
IPSC | $3.105 4.37% 22K
|
Professional, Scientific, and T...
|
| O: 0.17%
H: 5.68%
C: -3.88%
therapeutics results
Virios Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-11 (Crawled : 12:00) - biospace.com/
VIRI | $0.4499 13K
|
Health Technology
|
| O: 2.67%
H: 9.2%
C: 5.63%
therapeutics update results
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0606 68.33% 250M
|
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
PRTG | $0.285 18.75% 170K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.